Ballon, J., Savage, P. "., Agarwal, A. D., Jeffrey, S., Syed, S., Woolsey, L., Xayasak, V., Arakelyan, S., Moradkhani, A. M., Chua-Alcala, V. S., Wong, S., Quon, D. V., Chawla, S. P., Chawla, N. S., Gordon, E. M. (2025). A phase 2 study using metronomic gemcitabine, doxorubicin, and docetaxel plus nivolumab in advanced leiomyosarcoma and liposarcoma (NCT04535713).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.11515